Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (201-210 of 304) with videos related to

Pageof 31
Sort By:
Oncoimmunology|November 22, 2012
Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cellsRolf Kiessling, Riki Okita, Dimitrios Mougiakakos, et al.
Oncoimmunology|December 8, 2018
Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burdenJan Budczies, Anja Seidel, Petros Christopoulos, et al.
Oncotarget|April 20, 2015
Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolismSandra Leisz, Kristin Schulz, Susanne Erb, et al.
Oncotarget|September 3, 2016
HLA-E expression and its clinical relevance in human renal cell carcinomaBarbara Seliger, Simon Jasinski-Bergner, Dagmar Quandt, et al.
Journal of Clinical Medicine|August 23, 2020
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in MelanomaMaria-Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Oncoimmunology|December 19, 2022
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapyChristoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, et al.
European Journal of Immunology|July 21, 2018
Kallikrein-related peptidases are activators of the CC chemokine CCL14Mario Grünberg, Dagmar Quandt, Holger Cynis, et al.
Clinical Immunology (Orlando, Fla.)|April 13, 2011
Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formationGunter Rappl, Stefan Pabst, Dagmar Riemann, et al.
Journal of Ethnopharmacology|June 20, 2014
Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behaviorClaudia Bobach, Jana Schurwanz, Katrin Franke, et al.
Oncotarget|November 20, 2019
Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanomaJohannes Fänder, Heike Kielstein, Maximilian Büttner, et al.
Pageof 31

Showing results (201-210 of 304) with videos related to

Sort By:
Pageof 31
Oncoimmunology|November 22, 2012
Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cellsRolf Kiessling, Riki Okita, Dimitrios Mougiakakos, et al.
Oncoimmunology|December 8, 2018
Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burdenJan Budczies, Anja Seidel, Petros Christopoulos, et al.
Oncotarget|April 20, 2015
Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolismSandra Leisz, Kristin Schulz, Susanne Erb, et al.
Oncotarget|September 3, 2016
HLA-E expression and its clinical relevance in human renal cell carcinomaBarbara Seliger, Simon Jasinski-Bergner, Dagmar Quandt, et al.
Journal of Clinical Medicine|August 23, 2020
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in MelanomaMaria-Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Oncoimmunology|December 19, 2022
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapyChristoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, et al.
European Journal of Immunology|July 21, 2018
Kallikrein-related peptidases are activators of the CC chemokine CCL14Mario Grünberg, Dagmar Quandt, Holger Cynis, et al.
Clinical Immunology (Orlando, Fla.)|April 13, 2011
Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formationGunter Rappl, Stefan Pabst, Dagmar Riemann, et al.
Journal of Ethnopharmacology|June 20, 2014
Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behaviorClaudia Bobach, Jana Schurwanz, Katrin Franke, et al.
Oncotarget|November 20, 2019
Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanomaJohannes Fänder, Heike Kielstein, Maximilian Büttner, et al.
Pageof 31